Nottingham UK – 13 October 2020. BioCity, the pioneering life science incubator and business collective, supported by education charity Ignite! brought together ninety students from five Nottingham secondary schools, to celebrate the legacy of the celebrated Nottingham mathematician, Ada Lovelace, to inspire young women into STEM...
Over 190 individuals from across the Healthcare and Life Sciences sector came together online, on Thursday 8 October to celebrate success at the Medilink UK National Awards. The awards recognised a multitude of achievements and outstanding contributions to the Life Sciences industry, and five companies from...
Story via Scotland Herald A total of 33 businesses with high growth potential have received just more than £1 million in funding after being named winners in the latest round of the Scottish EDGE Awards, with Edinburgh-based Touchlab scooping the biggest prize of £100,000. Set up in...
SurePulse Medical Ltd, a neonatal medtech spinout from the University of Nottingham is set to explore foreign markets and grow its product portfolio thanks to £1m secured from existing and new private investors. SurePulse Medical Ltd, based at MediCity in Nottingham, was established in 2014 as...
Double Olympic champion, Commonwealth champion, and multiple world champion Alistair Brownlee (MBE) joins Incus Performance, as investor and strategic advisor. Alistair brings 15 years of experience at the highest level and will use this knowledge to help further develop the INCUS platform and product offering to...
OUTbio are delighted to announce the formation of the UK branch of OUTbio – an independent network run specifically for the LGBTQ community and its allies within the biotech community in the UK. We hosted our inaugural event on 30th September and virtually connected members...
A selection of the best and brightest talents in life sciences have been shortlisted for the national Medilink UK Healthcare Business Awards 2020, sponsored by Grant Thornton LLP. Finalists based at BioCity include Sygnature Discovery, XenoGesis, Surepulse Medical and investee Sentinel. Over 40 companies encompassing the length...
Coventry, UK, 30th September 2020 / Sciad Newswire / NanoSyrinx, an emerging biotechnology company developing new therapeutic modalities for Cell & Gene editing, announced the closing of a Pre-Seed financing led by M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of Merck. BioCity (Nottingham, United Kingdom) and...
XenoGesis has been acquired by leading drug discovery CRO, Sygnature Discovery, strengthening the combined DMPK offering and enhancing existing capabilities and expertise. This latest acquisition by Sygnature serves to meet the increasing demand for DMPK services and boosts the company’s reach into the pre-clinical space. XenoGesis’ novel...
BioCity, Nottingham based Sygnature Discovery, a world-leading integrated discovery and pre-clinical solutions provider, has appointed Dr Andy Mead as Director and Head of Drug Abuse and Substance Use Disorders at its integrated in vivo pharmacology company, RenaSci. With 25 years’ experience in the science of...